General Information of the Compound
| Compound ID |
CP0398003
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-chloro-N-[3-(2-pyrrolidin-1-ylethyl)imidazo[4,5-b]pyridin-2-yl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H20ClN5O
|
||||||||||||||||||
| Molecular Weight |
369.856
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc(cc1)C(=O)Nc1nc2cccnc2n1CCN1CCCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H20ClN5O/c20-15-7-5-14(6-8-15)18(26)23-19-22-16-4-3-9-21-17(16)25(19)13-12-24-10-1-2-11-24/h3-9H,1-2,10-13H2,(H,22,23,26)
Show/Hide
|
||||||||||||||||||
| InChIKey |
COPRXHFVKPODSK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01200, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor